When medicines change our behaviour – New podcast out now

Research / 02 May 2024

Adverse effects to medicines are not just physical in nature, but can manifest as behavioural side-effects too. How do we diagnose and treat these complex ADRs?


Drug-induced impulse control disorders have the potential to negatively impact overall quality of life, but are especially hard to identify, diagnose, and treat. In the latest Drug Safety Matters podcast, Michele Fusaroli of the University of Bologna describes which types of medicines are most likely to cause these impulsive behaviours, and how listening to patient stories can be a huge help in their detection and treatment.

Subscribe by visiting the Drug Safety Matters website or listen to the podcast here:

Related Articles

Artificial intelligence in pharmacovigilance: Harnessing potential, navigating risks

A guide to reporting disproportionality analyses – New podcast episode

Mind the gap: Preventing medication errors after hospital discharge

You may also like

Mind the gap: Preventing medication errors after hospital discharge

Medication errors are a key pharmacovigilance issue, especially as patients transition between secondary and primary care as they readjust to life outside of hospital.

Research / 09 September 2024

Artificial intelligence in pharmacovigilance: Harnessing potential, navigating risks

AI holds potential to transform pharmacovigilance. But navigating the risks requires critical assessment. This article explores AI's evolving role in medicines safety.

Research / 22 October 2024

A guide to reporting disproportionality analyses – New podcast episode

The READUS-PV statement is the first-ever guide for reports of disproportionality analyses that are replicable, reliable, and reproducible.

Research / 07 October 2024